OncoMax is a private biotechnology company founded in 2010 with the goal of developing and launching new diagnostic and therapeutic anti-cancer agents. The company is a participant of Technology Platform “Medicine of the Future” and a Skolkovo resident awarded with a Skolkovo Foundation grant. In early 2012 OncoMax has been awarded as the best deal of year 2011 in “venture and direct investment” nomination of Russian Investor Award.
Company Details
- Founded
- -
- Address
- Moscow City, Ru
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.oncomax.ru
- HQ
- Moscow City
Oncomax, Llc Questions
Oncomax, Llc's website is http://www.oncomax.ru
Oncomax, Llc's LinkedIn profile is https://ru.linkedin.com/company/oncomax-llc
Oncomax, Llc's industry is
Biotechnology Research
Oncomax, Llc's top competitors are
Oncon, Llc,
Ferment Group,
Spektronika Ltd.,
Oncomax,
Mirabo Systems International,
Epigene,
Newruslab Llc,
Rapid Bio, Llc.,
Lytech Co. Ltd. / Ооо Нпф "литех",
Ksitest.
Oncomax, Llc's categories are Biotechnology Research
Oncomax, Llc's founding year is 2010
